Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell of lymphatic vessel | 26 studies | 57% ± 18% | |
| oligodendrocyte | 12 studies | 27% ± 10% | |
| retina horizontal cell | 7 studies | 68% ± 15% | |
| hepatocyte | 6 studies | 58% ± 26% | |
| retinal bipolar neuron | 5 studies | 52% ± 19% | |
| cardiac muscle cell | 5 studies | 21% ± 3% | |
| GABAergic neuron | 5 studies | 36% ± 8% | |
| ON-bipolar cell | 4 studies | 45% ± 16% | |
| brush cell | 4 studies | 33% ± 20% | |
| interneuron | 4 studies | 49% ± 28% | |
| ionocyte | 3 studies | 28% ± 5% | |
| endothelial cell | 3 studies | 24% ± 10% | |
| glycinergic amacrine cell | 3 studies | 41% ± 1% | |
| rod bipolar cell | 3 studies | 72% ± 1% | |
| Mueller cell | 3 studies | 24% ± 8% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 9600.35 | 226 / 226 | 99% | 46.33 | 400 / 406 |
| brain | 95% | 1162.71 | 2517 / 2642 | 98% | 12.48 | 694 / 705 |
| adrenal gland | 100% | 2320.60 | 258 / 258 | 93% | 22.16 | 214 / 230 |
| intestine | 93% | 585.70 | 897 / 966 | 83% | 12.91 | 437 / 527 |
| pancreas | 100% | 2061.12 | 328 / 328 | 70% | 5.92 | 125 / 178 |
| thymus | 100% | 2374.79 | 651 / 653 | 48% | 2.83 | 291 / 605 |
| stomach | 46% | 179.16 | 164 / 359 | 71% | 14.79 | 203 / 286 |
| lung | 72% | 398.56 | 414 / 578 | 35% | 3.37 | 401 / 1155 |
| bladder | 71% | 359.14 | 15 / 21 | 33% | 5.42 | 166 / 504 |
| ovary | 100% | 1674.04 | 180 / 180 | 2% | 0.12 | 9 / 430 |
| spleen | 100% | 2105.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| heart | 93% | 2052.36 | 799 / 861 | 0% | 0 | 0 / 0 |
| muscle | 90% | 700.03 | 723 / 803 | 0% | 0 | 0 / 0 |
| breast | 69% | 603.28 | 319 / 459 | 14% | 0.74 | 158 / 1118 |
| esophagus | 43% | 203.10 | 622 / 1445 | 39% | 4.96 | 72 / 183 |
| adipose | 65% | 500.23 | 788 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 48% | 200.21 | 82 / 170 | 17% | 1.32 | 78 / 459 |
| skin | 30% | 131.67 | 541 / 1809 | 34% | 2.17 | 162 / 472 |
| prostate | 37% | 140.96 | 90 / 245 | 10% | 0.39 | 51 / 502 |
| kidney | 33% | 376.92 | 29 / 89 | 7% | 0.43 | 64 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 1.41 | 10 / 45 |
| blood vessel | 14% | 95.84 | 186 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 11% | 0.53 | 9 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.22 | 2 / 29 |
| peripheral blood | 0% | 0.95 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006366 | Biological process | transcription by RNA polymerase II |
| GO_0010468 | Biological process | regulation of gene expression |
| GO_0060059 | Biological process | embryonic retina morphogenesis in camera-type eye |
| GO_0045071 | Biological process | negative regulation of viral genome replication |
| GO_0030324 | Biological process | lung development |
| GO_0060298 | Biological process | positive regulation of sarcomere organization |
| GO_0061114 | Biological process | branching involved in pancreas morphogenesis |
| GO_0043049 | Biological process | otic placode formation |
| GO_0060838 | Biological process | lymphatic endothelial cell fate commitment |
| GO_0060214 | Biological process | endocardium formation |
| GO_2000179 | Biological process | positive regulation of neural precursor cell proliferation |
| GO_0060042 | Biological process | retina morphogenesis in camera-type eye |
| GO_0060414 | Biological process | aorta smooth muscle tissue morphogenesis |
| GO_0090425 | Biological process | acinar cell differentiation |
| GO_0060837 | Biological process | blood vessel endothelial cell differentiation |
| GO_0048845 | Biological process | venous blood vessel morphogenesis |
| GO_1901978 | Biological process | positive regulation of cell cycle checkpoint |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0097150 | Biological process | neuronal stem cell population maintenance |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0001822 | Biological process | kidney development |
| GO_0055005 | Biological process | ventricular cardiac myofibril assembly |
| GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
| GO_0042752 | Biological process | regulation of circadian rhythm |
| GO_0060412 | Biological process | ventricular septum morphogenesis |
| GO_0072574 | Biological process | hepatocyte proliferation |
| GO_0021707 | Biological process | cerebellar granule cell differentiation |
| GO_0070365 | Biological process | hepatocyte differentiation |
| GO_0045787 | Biological process | positive regulation of cell cycle |
| GO_0007405 | Biological process | neuroblast proliferation |
| GO_0007406 | Biological process | negative regulation of neuroblast proliferation |
| GO_0070858 | Biological process | negative regulation of bile acid biosynthetic process |
| GO_0031016 | Biological process | pancreas development |
| GO_0060836 | Biological process | lymphatic endothelial cell differentiation |
| GO_0010631 | Biological process | epithelial cell migration |
| GO_0021542 | Biological process | dentate gyrus development |
| GO_0001946 | Biological process | lymphangiogenesis |
| GO_0001889 | Biological process | liver development |
| GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
| GO_0060421 | Biological process | positive regulation of heart growth |
| GO_0002194 | Biological process | hepatocyte cell migration |
| GO_0007420 | Biological process | brain development |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0055009 | Biological process | atrial cardiac muscle tissue morphogenesis |
| GO_0030240 | Biological process | skeletal muscle thin filament assembly |
| GO_0046619 | Biological process | lens placode formation involved in camera-type eye formation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0021516 | Biological process | dorsal spinal cord development |
| GO_0010595 | Biological process | positive regulation of endothelial cell migration |
| GO_0030910 | Biological process | olfactory placode formation |
| GO_0045737 | Biological process | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO_2000979 | Biological process | positive regulation of forebrain neuron differentiation |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0007623 | Biological process | circadian rhythm |
| GO_0031667 | Biological process | response to nutrient levels |
| GO_0048664 | Biological process | neuron fate determination |
| GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
| GO_0070309 | Biological process | lens fiber cell morphogenesis |
| GO_0002088 | Biological process | lens development in camera-type eye |
| GO_0021915 | Biological process | neural tube development |
| GO_0005634 | Cellular component | nucleus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005829 | Cellular component | cytosol |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0050693 | Molecular function | LBD domain binding |
| GO_0000976 | Molecular function | transcription cis-regulatory region binding |
| GO_0050692 | Molecular function | DNA binding domain binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003677 | Molecular function | DNA binding |
| GO_0016922 | Molecular function | nuclear receptor binding |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| Gene name | PROX1 |
| Protein name | Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1) (PROX-1) Prospero homeobox 1 |
| Synonyms | |
| Description | FUNCTION: Transcription factor involved in developmental processes such as cell fate determination, gene transcriptional regulation and progenitor cell regulation in a number of organs. Plays a critical role in embryonic development and functions as a key regulatory protein in neurogenesis and the development of the heart, eye lens, liver, pancreas and the lymphatic system. Involved in the regulation of the circadian rhythm. Represses: transcription of the retinoid-related orphan receptor RORG, transcriptional activator activity of RORA and RORG and the expression of RORA/G-target genes including core clock components: BMAL1, NPAS2 and CRY1 and metabolic genes: AVPR1A and ELOVL3. . |
| Accessions | ENST00000366958.9 C9JU29 Q92786 ENST00000435016.2 ENST00000471129.1 U3KPY6 ENST00000607425.1 |